“We are pleased to enter into our first global agreement for ALT-B4 with an experienced top pharmaceutical company,” said Dr. Soon Jae Park, Chief Executive Officer of Alteogen.

Under the terms of the agreement, Sandoz will acquire the world-wide rights to use ALT-B4, Alteogen’s novel hyaluronidase derived utilizing Hybrozyme™ Technology, to develop and commercialize ...

The LG B4 might be this year's most value-centric OLED, and it keeps coming down in price. ... We check over 250 million products every day for the best prices. TOPICS. Hisense. See all comments (0) ...